Eli Lilly and Company: all 2,262 studies
Page 5 of 23. Open to participants first (177), then studies with results posted, then the rest; newest registration first within each.
- A Study of Tirzepatide in Chinese Participants With Type 2 Diabetes MellitusCompletedNCT04235959Phase 1Results posted
- A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Crohn's DiseaseActive, not recruitingNCT04232553Phase 3Results posted
- A Study of LY3478006 in Healthy ParticipantsTerminatedNCT04230122Phase 1Results posted
- A Study of Selpercatinib (LY3527723) in Participants With RET-Mutant Medullary Thyroid CancerActive, not recruitingNCT04211337Phase 3Results posted
- A Study of Selpercatinib (LY3527723) in Participants With Advanced or Metastatic RET Fusion-Positive Non-Small Cell Lung CancerActive, not recruitingNCT04194944Phase 3Results posted
- A Crossover Study to Evaluate Pegilodecakin (LY3500518) in Healthy ParticipantsCompletedNCT04194892Phase 1Results posted
- A Study of Tirzepatide (LY3298176) in Participants With Obesity or OverweightCompletedNCT04184622Phase 3Results posted
- A Study of LY3526318 in Healthy WomenCompletedNCT04183283Phase 1Results posted
- Evaluation of the Efficacy and Safety of Lebrikizumab (LY3650150) in Moderate to Severe Atopic DermatitisCompletedNCT04178967Phase 3Results posted
- A Safety Study of LY3493269 Given as a Single Injection in Healthy ParticipantsCompletedNCT04178733Phase 1Results posted
- A Study of the Effect of Tirzepatide on How the Body Handles Birth Control Pills in Healthy Female ParticipantsCompletedNCT04172987Phase 1Results posted
- A Study of Tirzepatide (LY3298176) in Participants With Nonalcoholic Steatohepatitis (NASH)CompletedNCT04166773Phase 2Results posted
- A Study of LY3499446 in Participants With Advanced Solid Tumors With KRAS G12C MutationTerminatedNCT04165031Phase 1/2Results posted
- A Study of LY3454738 in Adults With Chronic Spontaneous UrticariaTerminatedNCT04159701Phase 2Results posted
- A Study of Insulin Glargine (LY2963016) in Adult Participants With Type 2 Diabetes in IndiaCompletedNCT04153981Phase 4Results posted
- A Study of the CD73 Inhibitor LY3475070 Alone or in Combination With Pembrolizumab in Participants With Advanced CancerCompletedNCT04148937Phase 1Results posted
- Evaluation of the Efficacy and Safety of Lebrikizumab (LY3650150) in Moderate to Severe Atopic Dermatitis (ADvocate1)CompletedNCT04146363Phase 3Results posted
- CAMPFIRE: A Study of Ramucirumab (LY3009806) in Children and Young Adults With Synovial SarcomaTerminatedNCT04145700Phase 1/2Results posted
- CAMPFIRE: A Study of Ramucirumab (LY3009806) in Children and Young Adults With Desmoplastic Small Round Cell TumorCompletedNCT04145349Phase 1/2Results posted
- A Study of Mirikizumab in Healthy Chinese ParticipantsCompletedNCT04137380Phase 1Results posted
- A Study of LY3435151 in Participants With Solid TumorsTerminatedNCT04099277Phase 1Results posted
- A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes on Metformin With or Without Sulfonylurea (SURPASS-AP-Combo)CompletedNCT04093752Phase 3Results posted
- A Study of Baricitinib (LY3009104) in Participants From 2 Years to Less Than 18 Years Old With Active JIA-Associated Uveitis or Chronic Anterior Antinuclear Antibody-Positive UveitisActive, not recruitingNCT04088409Phase 3Results posted
- A Study of Baricitinib in Participants With Rheumatoid ArthritisCompletedNCT04086745Phase 4Results posted
- A Study of Galcanezumab (LY2951742) in Healthy Chinese ParticipantsCompletedNCT04085289Phase 1Results posted
- A Study to Measure Energy Expenditure and Food Intake in Participants With Obesity Using TirzepatideCompletedNCT04081337Phase 1Results posted
- A Study of Lasmiditan in Healthy Chinese ParticipantsCompletedNCT04081324Phase 1Results posted
- A Study of Tirzepatide at Different Injection Sites in Participants With Different Body SizesCompletedNCT04050670Phase 1Results posted
- A Study of Tirzepatide in Participants With Type 2 Diabetes MellitusCompletedNCT04050553Phase 1Results posted
- A Study of LY900014 in Healthy Chinese ParticipantsCompletedNCT04049123Phase 1Results posted
- A Study of Tirzepatide (LY3298176) Versus Placebo in Participants With Type 2 Diabetes Inadequately Controlled on Insulin Glargine With or Without MetforminCompletedNCT04039503Phase 3Results posted
- A Study of Abemaciclib (LY2835219) in Combination With Fulvestrant Compared to Chemotherapy in Women With HR Positive, HER2 Negative Metastatic Breast CancerTerminatedNCT04031885Phase 4Results posted
- A Study of LY3154885 in Healthy ParticipantsTerminatedNCT04014361Phase 1Results posted
- A Study of Tirzepatide Administered by Two Different Devices in Healthy ParticipantsCompletedNCT04004988Phase 1Results posted
- A Study of Mirikizumab (LY3074828) in Children and Teenagers With Ulcerative Colitis (UC)CompletedNCT04004611Phase 2Results posted
- A Study of Lasmiditan (LY573144) in Children Aged 6 to 17 With MigraineCompletedNCT03988088Phase 1Results posted
- A Study of Tirzepatide (LY3298176) Versus Semaglutide Once Weekly as Add-on Therapy to Metformin in Participants With Type 2 DiabetesCompletedNCT03987919Phase 3Results posted
- A Study of LY3526318 in Healthy ParticipantsTerminatedNCT03977974Phase 1Results posted
- A Study of Galcanezumab (LY2951742) in Participants With Episodic MigraineCompletedNCT03963232Phase 3Results posted
- A Study Lasmiditan (LY573144) in a Single Migraine Attack in Japanese Participants With MigraineCompletedNCT03962738Phase 2Results posted
- A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Not Controlled With Diet and Exercise AloneCompletedNCT03954834Phase 3Results posted
- A Study of Baricitinib (LY3009104) in Children and Adolescents With Atopic DermatitisCompletedNCT03952559Phase 3Results posted
- A Study of LY900014 Compared to Insulin Lispro (Humalog) in Adults With Type 2 DiabetesCompletedNCT03952143Phase 3Results posted
- A Study of LY900014 Compared to Insulin Lispro (Humalog) in Adults With Type 1 DiabetesCompletedNCT03952130Phase 3Results posted
- A Study of Tirzepatide in Participants With Type 2 Diabetes Mellitus (T2DM)CompletedNCT03951753Phase 1Results posted
- A Study of Ixekizumab (LY2439821) in Participants in Japan With Generalized Pustular Psoriasis and Erythrodermic PsoriasisCompletedNCT03942042Phase 4Results posted
- A Study of Tirzepatide in Participants With Impaired Liver FunctionCompletedNCT03940742Phase 1Results posted
- A Study of LY3434172, a PD-1 and PD-L1 Bispecific Antibody, in Advanced CancerTerminatedNCT03936959Phase 1Results posted
- A Study of LY3502970 in Healthy ParticipantsCompletedNCT03929744Phase 1Results posted
- A Study of Mirikizumab (LY3074828) in Participants With Crohn's DiseaseCompletedNCT03926130Phase 3Results posted
- A Study of Baricitinib (LY3009104) in Participants With Rheumatoid ArthritisCompletedNCT03915964Phase 4Results posted
- Evaluation of Flortaucipir PET Signal and Cognitive Change in Early Alzheimer's DiseaseCompletedNCT03901105Phase 3Results posted
- A Reader Study to Assess Accuracy and Reliability of Flortaucipir F 18 Positron Emission Tomography (PET) Scan InterpretationCompletedNCT03901092Phase 3Results posted
- A Study of Oral LOXO-292 (Selpercatinib) in Pediatric Participants With Advanced Solid or Primary Central Nervous System (CNS) TumorsActive, not recruitingNCT03899792Phase 1/2Results posted
- A Study of Baricitinib (LY3009104) in Adults With Severe or Very Severe Alopecia AreataCompletedNCT03899259Phase 3Results posted
- A Study of Injections of LY3074828 in Healthy ParticipantsCompletedNCT03886948Phase 1Results posted
- A Study of Tirzepatide (LY3298176) Versus Insulin Degludec in Participants With Type 2 DiabetesCompletedNCT03882970Phase 3Results posted
- A Study of Tirzepatide (LY3298176) Compared to Dulaglutide in Participants With Type 2 DiabetesCompletedNCT03861052Phase 3Results posted
- A Long-term Safety Study of Tirzepatide (LY3298176) in Participants With Type 2 DiabetesCompletedNCT03861039Phase 3Results posted
- A Study of Ixekizumab in Healthy ParticipantsCompletedNCT03848416Phase 1Results posted
- Study of Ixekizumab in Healthy ParticipantsTerminatedNCT03848403Phase 1Results posted
- A Study of Baricitinib in Participants With Systemic Lupus Erythematosus (SLE)TerminatedNCT03843125Phase 3Results posted
- A Study of LY3375880 in Adults With Moderate-to-Severe Atopic DermatitisTerminatedNCT03831191Phase 2Results posted
- A Study Comparing LY900014 to Insulin Lispro (Humalog) in Adults With Type 1 Diabetes Using Insulin Pump TherapyCompletedNCT03830281Phase 3Results posted
- Long-Term Follow-up Study of ADVM-043CompletedNCT03804021Results posted
- A Study of Baricitinib in Participants From 2 Years to Less Than 18 Years Old With Juvenile Idiopathic ArthritisCompletedNCT03773978Phase 3Results posted
- A Study of LY3405105 in Participants With Advanced CancerTerminatedNCT03770494Phase 1Results posted
- A Study Comparing User Experience of Different Delivery Devices for GlucagonCompletedNCT03765502Phase 1Results posted
- A Study of LY3463251 in Healthy ParticipantsTerminatedNCT03764774Phase 1Results posted
- A Study of LY900014 in a Medtronic PumpCompletedNCT03760640Phase 2Results posted
- A Study of LY3415244 in Participants With Advanced Solid TumorsTerminatedNCT03752177Phase 1Results posted
- A Study of Baricitinib (LY3009104) in Participants With Primary Biliary Cholangitis Who do Not Respond or Cannot Take UDCATerminatedNCT03742973Phase 2Results posted
- A Study Comparing LY900014 to Insulin Lispro (Humalog) in Children and Adolescents With Type 1 DiabetesCompletedNCT03740919Phase 3Results posted
- A Study of LY3209590 in Participants With Type 2 Diabetes MellitusCompletedNCT03736785Phase 2Results posted
- A Study of Baricitinib (LY3009104) in Combination With Topical Corticosteroids in Adults With Moderate to Severe Atopic DermatitisCompletedNCT03733301Phase 3Results posted
- A Study of Tirzepatide (LY3298176) Once a Week Versus Insulin Glargine Once a Day in Participants With Type 2 Diabetes and Increased Cardiovascular RiskCompletedNCT03730662Phase 3Results posted
- A Study Comparing the Dulaglutide Pen and the Semaglutide PenCompletedNCT03724981Phase 4Results posted
- A Study of Mirikizumab in Participants With Plaque PsoriasisCompletedNCT03718884Phase 1Results posted
- A Study of Abiraterone Acetate Plus Prednisone With or Without Abemaciclib (LY2835219) in Participants With Prostate CancerActive, not recruitingNCT03706365Phase 2/3Results posted
- A Study of Abemaciclib (LY2835219) With and Without Food in Participants With Metastatic Breast CancerCompletedNCT03703466Phase 2Results posted
- A Study of LY3451838 in Healthy ParticipantsCompletedNCT03692949Phase 1Results posted
- A Study of Lasmiditan (LY573144) Over Four Migraine AttacksCompletedNCT03670810Phase 3Results posted
- A Study of Two Formulations of LY3074828 in Healthy ParticipantsCompletedNCT03662100Phase 1Results posted
- Study to Compare 2 Formulations of LY900014 in Healthy ParticipantsCompletedNCT03616977Phase 1Results posted
- A Study of Baricitinib in Participants With Systemic Lupus Erythematosus (SLE-BRAVE II)CompletedNCT03616964Phase 3Results posted
- A Study of Baricitinib (LY3009104) in Participants With Systemic Lupus ErythematosusTerminatedNCT03616912Phase 3Results posted
- A Study of LY3316531 in Healthy ParticipantsCompletedNCT03611608Phase 1Results posted
- A Study of Lasmiditan in Healthy Japanese and Caucasian ParticipantsCompletedNCT03579940Phase 1Results posted
- A Study of Ixekizumab (LY2439821) Compared to Guselkumab in Participants With Moderate-to-Severe Plaque PsoriasisCompletedNCT03573323Phase 4Results posted
- A Study of Baricitinib (LY3009104) in Participants With Severe or Very Severe Alopecia AreataCompletedNCT03570749Phase 2/3Results posted
- A Study of Baricitinib (LY3009104) in Participants With Moderate to Severe Atopic DermatitisTerminatedNCT03559270Phase 3Results posted
- A Study of Galcanezumab (LY2951742) in Adults With Treatment-Resistant MigraineCompletedNCT03559257Phase 3Results posted
- A Long-term Study to Evaluate Safety and Maintenance of Treatment Effect of LY3074828 in Participants With Moderate-to-Severe Plaque Psoriasis (OASIS-3)TerminatedNCT03556202Phase 3Results posted
- A Study of Insulin Glargine (LY2963016) in Healthy Chinese ParticipantsCompletedNCT03555305Phase 1Results posted
- A Study to Assess if Mirikizumab is Effective and Safe Compared to Secukinumab and Placebo in Moderate to Severe Plaque Psoriasis (OASIS-2)CompletedNCT03535194Phase 3Results posted
- A Maintenance Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative ColitisCompletedNCT03524092Phase 3Results posted
- An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)CompletedNCT03518086Phase 3Results posted
- A Study of LY3303560 in Participants With Early Symptomatic Alzheimer's DiseaseCompletedNCT03518073Phase 2Results posted
- A Study of the Efficacy and Safety of Dulaglutide (LY2189265) in Participants With Type 2 DiabetesCompletedNCT03495102Phase 3Results posted
- A Study of Tirzepatide (LY3298176) in Participants With Impaired Kidney FunctionCompletedNCT03482024Phase 1Results posted